Company intelligence / Profile preview
Innovative Biopharmaceuticals
London, United Kingdominnovativebioresearch.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Innovative Bioresearch is a privately held biotechnology company focused on developing novel therapies for HIV, cancer, and regeneration. The company's research portfolio includes the development of a cell-based therapy for HIV cure and innovative approaches to targeting solid tumors. Beyond its core therapeutic research, the company has explored the integration of blockchain technology for clinical data management and decentralized health solutions. Innovative Bioresearch aims to bridge the gap between academic discovery and clinical application through its proprietary research programs.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Cell therapyGene therapyMonoclonal antibodySmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Innovative Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innovative Biopharmaceuticals.